NFIB, variants, traits, and what the research shows

NFIB - what this gene does

NFIB is a gene whose catalogued variants point primarily toward rare disease conditions, with one additional association in musculoskeletal traits. No published summaries are yet attached to individual variants in this dataset, so this entry describes the gene by the trait categories its variants fall into.

Key takeaways

• Most of the 139 catalogued variants in this gene are linked to the rare disease category, suggesting relevance to conditions that affect a small share of the population.
• One variant is flagged under musculoskeletal traits, pointing toward possible relevance to bone, joint, or connective tissue.
• Fourteen variants carry the top magnitude score of 5.50, all in the rare disease category.
• Detailed trait information for individual variants is not yet available in this dataset.
• These are population-level statistical signals, not guaranteed outcomes for any individual.

Notable variants

The strongest signals on file all sit in the rare disease category. Fourteen variants share the top magnitude score of 5.50: rs1191193223, rs1268417773, rs1554639173, rs1554649366, rs1554709683, rs1554709792, rs2060062099, rs2537829946, rs2538098365, rs2538135168, rs2538994311, rs2539031078, rs753551959, and rs966707448. At magnitude 5.00, five additional rare disease variants are on file: rs1011357372, rs1364033144, rs1554709654, rs1587053767, and rs1588253471. The sole musculoskeletal entry at this tier is rs1554709662.

Trait associations

Rare disease is the dominant theme across all 20 listed variants, with 19 of the 20 falling into that category. The lone exception, rs1554709662, is flagged under musculoskeletal traits. Because no individual SNP summaries have been published for this gene in the current dataset, the specific conditions or mechanisms driving these associations are not detailed here.

Evidence quality

The 20 variants shown represent a subset of 139 total variants on file; the full picture may change as more summaries are published. Magnitude scores of 5.00 to 5.50 indicate moderate-to-strong signals within the internal ranking used by this database, but without accompanying sample sizes, odds ratios, or replication information, the strength and consistency of the external evidence base cannot be independently assessed at this time. These findings should be treated as preliminary pointers rather than settled conclusions.

What this is NOT

These variants are population-level statistical signals identified through studies such as GWAS (genome-wide association study, a method that scans the genomes of many people for variants statistically linked to a trait), not deterministic predictors of any outcome for any individual. This entry does not constitute medical advice, a diagnosis, or a recommendation of any kind.